# A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

> **NCT06660290** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 55 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** 0.003% AR-15512 ophthalmic solution
- **DRUG:** Artificial tears

## Key facts

- **NCT ID:** NCT06660290
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-15
- **Primary completion:** 2025-02-06
- **Final completion:** 2025-02-06
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06660290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06660290, "A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT06660290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*